QDEL:NASDAQ
Quidelortho Corp
$10.38
arrow_downward
-1.52%(-0.16) 1D
$10.49
arrow_upward
+1.09% (+0.11)todayPre-market
Closed: Oct 1, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$10.55
High
$10.64
Low
$9.93
Mkt. cap
711.81M
Avg. vol.
1.37M
Volume
0.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
Open
$10.55
High
$10.64
Low
$9.93
Mkt. cap
711.81M
Avg. vol.
1.37M
Volume
0.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
FXLeaders
·
36 minutes ago
Dow Futures Drift Sideways as Investors Brace for Crucial Labor Market Data
VT Markets
·
42 minutes ago
US Futures Gain as SP500 Holds Near 7,680 Ahead of Jobs Data
Trefis
·
48 minutes ago
22 S&P 500 Stocks Hit 52-Week Lows On Thursday
Investor's Business Daily
·
8 hours ago
Twilio To Join S&P 500 Index
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com